Dynavax Technologies | Devedores Comerciais



Trade Debtors Alterar Data
AbbVie USD 10.92B 553M 2024-12
Adma Biologics USD 50M 141K 2024-12
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Dynavax Technologies USD 46.91M 28.37M 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
Glaxosmithkline GBP 7.32B 542M 2024-12
Merck USD 11.12B 1.06B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
TG Therapeutics USD 129.18M 13.46M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Dynavax Technologies Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.